Balanced news tone
News Sentiment
LILY34 sentiment intelligence
Eli Lilly and Company news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
79/100 classification confidence.
directly relevant articles
high-authority source matches
-2.9% over one week, +5.8% over four weeks, trend active, and materially above fair value.
Lilly to buy psychedelic firm AtaiBeckley for up to $3.8 billion
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Lilly to buy psychedelic firm AtaiBeckley for up to $3.8 billion
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Jul 2026 17:28
- Source
- Moneycontrol.com
Eli Lilly Stock - Analyst consensus stays bullish on weight-loss boom
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 20 Jun 2026 07:00
- Source
- ad-hoc-news.de
Eli Lilly targets vaccines market with $3.8B acquisition of three biotech firms
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 26 May 2026 07:00
- Source
- Proactive financial news
Eli Lilly New Drug Just Matched Bariatric Surgery Results. Why Did the Stock Barely Move?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 24 May 2026 07:00
- Source
- TIKR.com
Eli Lilly & Co. stock (US5324571083): Q1 revenues surge 56% on obesity drug boom
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- ad-hoc-news.de
NYSE Content Update: Eli Lilly to Celebrate 150 Years of Scientific Innovation
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- PR Newswire UK
BofA sees more upside in Eli Lilly stock
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 02 May 2026 07:00
- Source
- thestreet.com
Eli Lilly Reports $19.8B Q1 Revenue as GLP-1 Sales Surge 56% Year Over Year
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 01 May 2026 07:00
- Source
- TIKR.com
Lilly’s Strong GLP-1 Results Signal Robust Market Growth for Novo Nordisk says Barclays
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 30 Apr 2026 07:00
- Source
- Investing.com
Eli Lilly (LLY) Q1 2026 Earnings Transcript
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Apr 2026 07:00
- Source
- The Motley Fool
Healthcare Stocks Are Trading at a Deep Discount. Eli Lilly and Others Are Worth a Look.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Mar 2026 07:00
- Source
- Barron's
Eli Lilly, Micron among market cap stock movers on Tuesday
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Mar 2026 07:00
- Source
- Investing.com
Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar
- Tone
- Positive 66/100
- Event
- Guidance
- Published
- 04 Feb 2026 08:00
- Source
- CNBC
Eli Lilly's GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Feb 2026 08:00
- Source
- CNBC
Eli Lilly Stock Price (LLY) Holding On To $1000 Ahead of Earnings – What Next?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 Feb 2026 08:00
- Source
- AskTraders
Eli Lilly: Breakout To New Highs Sends A Clear Warning Shot (NYSE:LLY)
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 21 Jan 2026 08:00
- Source
- Seeking Alpha
Why Eli Lilly Stock Rose Almost 5% Last Week?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Nov 2025 07:00
- Source
- TIKR.com
Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 30 Oct 2025 07:00
- Source
- CNBC